Collaboration Details

Title of Collaborative Activity:

Memorandum of Understanding (MoU) between FDA/Center for Drug Evaluation and Research (CDER) and NIH/NINDS

Description of Collaborative Activity:

This MoU provides a mechanism for addressing cross-cutting issues related to drug evaluation and research for neurological disorders, from bench science to clinical studies and the Food and Drug Administration (FDA) approval.

Type of Collaborative Activity:

Other

Year the Collaborative Activity Originated:

2019

NIH Participating Institutes/Centers/Office of the Director:

HHS Agency Collaborators on this Activity:

FDA